Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
2(17%)
Results Posted
29%(2 trials)

Phase Distribution

Ph not_applicable
1
8%
Ph phase_1
6
50%
Ph phase_2
2
17%
Ph phase_4
1
8%
Ph early_phase_1
1
8%

Phase Distribution

7

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution11 total trials
Early Phase 1First-in-human
1(9.1%)
Phase 1Safety & dosage
6(54.5%)
Phase 2Efficacy & side effects
2(18.2%)
Phase 4Post-market surveillance
1(9.1%)
N/ANon-phased studies
1(9.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(7)
Other(3)

Detailed Status

Completed7
unknown3
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (9.1%)
Phase 16 (54.5%)
Phase 22 (18.2%)
Phase 41 (9.1%)
N/A1 (9.1%)

Trials by Status

completed758%
active_not_recruiting18%
unknown325%
recruiting18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
DRUG
Total Trials
12